(Q45871134)

17 December 2017

title

Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation (English)

1 reference

17 December 2017

main subject

hemophilia

0 references

coagulation factor IX

0 references

0 references

1 reference

S Björkman

1

1 reference

17 December 2017

M Carlsson

series ordinal

2

1 reference

17 December 2017

E Berntorp

series ordinal

3

1 reference

17 December 2017

publication date

1 January 1994

1 reference

17 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

17 December 2017

volume

46

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

325-332

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/bf00194400

exact match

0 references

cites work

Treatment of Hemophilia B with a New Clotting-Factor Concentrate

1 reference

12 December 2020

Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentrates.

1 reference

12 December 2020

Intra- and extravascular distribution of albumin and immunoglobulin in man

1 reference

12 December 2020

Plasma clearance rates of coagulation factors VIII and IX in factor-deficient individuals

1 reference

12 December 2020

In vivo recovery and half-life time of a steam-treated factor IX concentrate in hemophilia B patients. The influence of reagents and standards

1 reference

12 December 2020

Coagulation factor IX: successful surgical experience with a purified factor IX concentrate

1 reference

12 December 2020

Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates

1 reference

12 December 2020

Editorial: Filtration as the main mechanism of overall transcapillary protein escape from the plasma

1 reference

12 December 2020

Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies

1 reference

12 December 2020

Single-dose pharmacokinetics of factor IX evaluated by model-independent methods

1 reference

12 December 2020

Prediction of the normal blood volume. Relation of blood volume to body habitus

1 reference

12 December 2020

Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia B.

1 reference

12 December 2020

Binding of coagulation factors IX and X to the endothelial cell surface

1 reference

12 December 2020

Biochemical and in vivo properties of high purity factor IX concentrates

1 reference

12 December 2020

Labeled factor IX kinetics in patients with hemophilia-B.

1 reference

12 December 2020

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

1 reference

12 December 2020

Statistical estimations in pharmacokinetics.

1 reference

12 December 2020

Structure, function, and molecular defects of factor IX.

1 reference

12 December 2020

Definitions and Applications of Mean Transit and Residence Times in Reference to the Two-Compartment Mammillary Plasma Clearance Model

1 reference

12 December 2020

The relationship between alfentanil distribution kinetics and cardiac output.

1 reference

12 December 2020

Factor IX levels in patients with hemophilia B (Christmas disease) following transfusion with concentrates of factor IX or fresh frozen plasma (FFP).

1 reference

12 December 2020

Binding of factors IX and IXa to cultured vascular endothelial cells

1 reference

12 December 2020

The design and analysis of half-life and recovery studies for factor VIII and factor IX. Factor VIII/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis

1 reference

12 December 2020

Factor IX concentrates for clinical use.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00194400

1 reference

17 December 2017

Dimensions Publication ID

1035874509

0 references

1 reference

17 December 2017